These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8767842)

  • 41. Non-nucleoside reverse transcriptase inhibitors (NNRTIs): past, present, and future.
    De Clercq E
    Chem Biodivers; 2004 Jan; 1(1):44-64. PubMed ID: 17191775
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Compilation and prevalence of mutations associated with resistance to non-nucleoside reverse transcriptase inhibitors.
    Tambuyzer L; Azijn H; Rimsky LT; Vingerhoets J; Lecocq P; Kraus G; Picchio G; de Béthune MP
    Antivir Ther; 2009; 14(1):103-9. PubMed ID: 19320243
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pyrazole NNRTIs 1: design and initial optimisation of a novel template.
    Mowbray CE; Burt C; Corbau R; Perros M; Tran I; Stupple PA; Webster R; Wood A
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5599-602. PubMed ID: 19709880
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structure-based design, parallel synthesis, structure-activity relationship, and molecular modeling studies of thiocarbamates, new potent non-nucleoside HIV-1 reverse transcriptase inhibitor isosteres of phenethylthiazolylthiourea derivatives.
    Ranise A; Spallarossa A; Cesarini S; Bondavalli F; Schenone S; Bruno O; Menozzi G; Fossa P; Mosti L; La Colla M; Sanna G; Murreddu M; Collu G; Busonera B; Marongiu ME; Pani A; La Colla P; Loddo R
    J Med Chem; 2005 Jun; 48(11):3858-73. PubMed ID: 15916438
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Site-directed mutagenesis of HIV reverse transcriptase to probe enzyme processivity and drug binding.
    Beard WA; Wilson SH
    Curr Opin Biotechnol; 1994 Aug; 5(4):414-21. PubMed ID: 7520785
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Substituted tetrahydroquinolines as potent allosteric inhibitors of reverse transcriptase and its key mutants.
    Su DS; Lim JJ; Tinney E; Wan BL; Young MB; Anderson KD; Rudd D; Munshi V; Bahnck C; Felock PJ; Lu M; Lai MT; Touch S; Moyer G; Distefano DJ; Flynn JA; Liang Y; Sanchez R; Prasad S; Yan Y; Perlow-Poehnelt R; Torrent M; Miller M; Vacca JP; Williams TM; Anthony NJ
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5119-23. PubMed ID: 19631528
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polymorphism and drug-selected mutations in the reverse transcriptase gene of HIV-2 from patients living in southeastern France.
    Colson P; Henry M; Tivoli N; Gallais H; Gastaut JA; Moreau J; Tamalet C
    J Med Virol; 2005 Mar; 75(3):381-90. PubMed ID: 15648062
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 13: synthesis of fluorine-containing diaryltriazine derivatives for in vitro anti-HIV evaluation against wild-type strain.
    Xiong YZ; Chen FE; Balzarini J; De Clercq E; Pannecouque C
    Chem Biodivers; 2009 Apr; 6(4):561-8. PubMed ID: 19353537
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New alkenyldiarylmethanes with enhanced potencies as anti-HIV agents which act as non-nucleoside reverse transcriptase inhibitors.
    Cushman M; Casimiro-Garcia A; Hejchman E; Ruell JA; Huang M; Schaeffer CA; Williamson K; Rice WG; Buckheit RW
    J Med Chem; 1998 Jun; 41(12):2076-89. PubMed ID: 9622549
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 8. 8-Aryloxymethyl- and 8-arylthiomethyldipyridodiazepinones.
    Cywin CL; Klunder JM; Hoermann M; Brickwood JR; David E; Grob PM; Schwartz R; Pauletti D; Barringer KJ; Shih CK; Sorge CL; Erickson DA; Joseph DP; Hattox SE
    J Med Chem; 1998 Jul; 41(16):2972-84. PubMed ID: 9685236
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel, non-nucleoside inhibitor of HIV-1 reverse transcriptase.
    Merluzzi VJ; Rosenthal AS
    Adv Exp Med Biol; 1992; 312():89-94. PubMed ID: 1381140
    [No Abstract]   [Full Text] [Related]  

  • 52. [New chemical compounds with antiviral action].
    Herdewijn P
    Verh K Acad Geneeskd Belg; 1988; 50(4):349-65. PubMed ID: 2464877
    [No Abstract]   [Full Text] [Related]  

  • 53. Delavirdine mesylate, a potent non-nucleoside HIV-1 reverse transcriptase inhibitor.
    Freimuth WW
    Adv Exp Med Biol; 1996; 394():279-89. PubMed ID: 8815692
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical experience with non-nucleoside reverse transcriptase inhibitors: L-697,661 and nevirapine.
    Kilby JM; Saag MS
    Adv Exp Med Biol; 1996; 394():291-8. PubMed ID: 8815693
    [No Abstract]   [Full Text] [Related]  

  • 55. Betulinic acid and dihydrobetulinic acid derivatives as potent anti-HIV agents.
    Kashiwada Y; Hashimoto F; Cosentino LM; Chen CH; Garrett PE; Lee KH
    J Med Chem; 1996 Mar; 39(5):1016-7. PubMed ID: 8676334
    [No Abstract]   [Full Text] [Related]  

  • 56. [HEPT and its related compounds as anti-HIV agents].
    Miyasaka T; Tanaka H; Baba M
    Nihon Rinsho; 1993 Sep; 51 Suppl():200-6. PubMed ID: 7505847
    [No Abstract]   [Full Text] [Related]  

  • 57. Nucleoside spiroxiranes as suicide inhibitors of the human immunodeficiency virus.
    Bailey JM; Nelson KA
    Biochem Soc Trans; 1995 Nov; 23(4):619S. PubMed ID: 8654804
    [No Abstract]   [Full Text] [Related]  

  • 58. Pronounced Inhibition Shift from HIV Reverse Transcriptase to Herpetic DNA Polymerases by Increasing the Flexibility of α-Carboxy Nucleoside Phosphonates.
    John J; Kim Y; Bennett N; Das K; Liekens S; Naesens L; Arnold E; Maguire AR; Götte M; Dehaen W; Balzarini J
    J Med Chem; 2015 Oct; 58(20):8110-27. PubMed ID: 26450273
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and antiviral activity of 1,3-disubstituted uracils against HIV-1 and HCMV.
    Maruyama T; Kozai S; Yamasaki T; Witvrouw M; Pannecouque C; Balzarini J; Snoeck R; Andrei G; De Clercq E
    Antivir Chem Chemother; 2003 Sep; 14(5):271-9. PubMed ID: 14694990
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel methods of generating specific oligonucleotide inhibitors of viral polymerases.
    Chen H; Brown D; Gold L
    Methods Enzymol; 1996; 275():503-20. PubMed ID: 9026656
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.